Eli Lilly's experimental obesity drug shows over 11% weight loss in early trial

Published on 06/13/2025 at 18:39

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Eli Lilly and Company

Many US employers plan to pare health benefits as weight-loss spending soars	Jul. 17	RE
Trump Reportedly Says New Pharmaceutical Tariffs Likely by July-End	Jul. 16	MT
Biocon eyes generic Wegovy obesity drug launch in India, Canada in next 2 years, CEO says	Jul. 16	RE
Health Canada Expands Eli Lilly's Omvoh Indication to Crohn's, Approves Citrate-Free Formula	Jul. 16	MT
Kailera touts late-stage win for weight-loss drug in China	Jul. 15	RE
Health Rounds: Experimental Bayer drug eases menopause-like symptoms from breast cancer therapy	Jul. 11	RE
FDA May Fast Track Drug Reviews for Lower US Prices	Jul. 11	MT
FDA May Fast Track Drug Reviews for Lower US Prices, Bloomberg Reports	Jul. 11	MT
Guggenheim Adjusts Eli Lilly and Co.'s Price Target to $942 From $936, Keeps Buy Rating	Jul. 11	MT
Wall Street Waits to Hear the Numbers	Jul. 11
Eli Lilly and Co (India) with Association of Physicians of India announces launch of API - Obesity Gurukul - statement	Jul. 11	RE
Morgan Stanley Adjusts Price Target on Eli Lilly to $1,135 From $1,133, Maintains Overweight Rating	Jul. 10	MT
Sector Update: Health Care Stocks Higher Late Afternoon	Jul. 09	MT
Sector Update: Health Care	Jul. 09	MT
Öhman Health and New Technology Fund Rises 3.9% in June - Camurus Surges After Eli Lilly Partnership	Jul. 09	FW
Eli Lilly Seen Benefiting From Higher Zepbound Sales in Q2, BofA Says	Jul. 09	MT
Eli Lilly: new recommended dosage for Kisunla	Jul. 09
Eli Lilly and Company Announces FDA Approves Updated Label for Lilly's Kisunla (donanemab-azbt) with New Dosing in Early Symptomatic Alzheimer's Disease	Jul. 09	CI
Eli Lilly Gets FDA Approval for Updated Kisunla Dosing for Alzheimer's	Jul. 09	MT
Eli Lilly FDA approves updated label for Kisunla	Jul. 09	RE
US FDA approves gradual dosing for Lilly Alzheimer's drug	Jul. 09	RE
Trump says pharmaceutical tariffs could reach 200%	Jul. 08	RE
Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs	Jul. 08	MT
WeightWatchers names new medical chief, plans to offer menopause therapy and support	Jul. 08	RE
Sector Update: Tech	Jul. 07	MT